Not Signed In - Pharmos Completes Phase 1 Study Of Topical Diclofenac NanoEmulsion Cream
Wed, 15 Nov 2006 08:00 AM EST
... Pharmos Corporation (Nasdaq: PARS) announced today it has completed its initial analysis of data from a recently completed Phase 1 study of its proprietary NanoEmulsion topical drug delivery technology formulated with diclofenac. Diclofenac is an approved and widely-used non-steroidal anti-inflammatory drug (NSAID). [click link for full article] ...
Related Topics
- Diclofenac
- Diclofenac Topical
- Fluorouracil Topical
- Betamethasone Topical
- Ketoconazole Topical
- Hydrocortisone, Neomycin, and Polymyxin Topical
- Metronidazole Topical
- Betamethasone
- Benzocaine Topical
- Ciclopirox Topical
- Gentamicin Topical
- Clobetasol
- Diclofenac and Misoprostol
- Lidocaine and Prilocaine Topical
- Hydrocortisone Topical
- Doxepin Topical
- Hydrocortisone and Pramoxine Topical
- Fluocinonide Topical
- Amphotericin B Topical
- Triamcinolone Topical
email this page
print this page
bookmark this page
feedback on this page
